Fig. 4From: Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancerCD8+CD28− T-cell counts (a); Treg-cell counts (b); CD4+ T-cell counts (c); CD8+ T-cell counts (d); CD8/Treg ratios (e); and CD8/CD4 ratios (f) in responsive and non-responsive patients 1 month after SABRBack to article page